Business ❯ Pharmaceutical Industry

Market Dynamics

Pricing Strategies Drug Pricing Drug Pricing Strategies Drug Sales Competition Generic Drugs Supply Chain Drug Competition Drug Development Stock Performance

U.S. Drug Prices Fall at Fastest Pace in 63 Years, CMS Says

The administration says new price‑matching deals and an expanded TrumpRx platform are driving lower retail pharmacy prices

FDA Advisory Panel Narrowly Backs Compounding of Six Unapproved Peptides

Sanofi Confirms Intermittent U.S. Supply of Lantus SoloStar Pens

CVS Caremark Restores Zepbound and Adds Lilly’s Foundayo to Standard Formularies

Health Canada Approves Apotex’s Generic Ozempic, Opening Canada’s Market to Lower-Cost Semaglutide

Brazil Moves to Tighten Rules on GLP‑1 Weight‑Loss Pens as Demand Surges

NHS Warns Some Medicines Could Run Out in Days as Hormuz Disruption Bites

Brazil Sets 2026 Medicine Price Caps With Three-Tier Increases Up to 3.81%

India Tightens Oversight of GLP-1 Drugs as Semaglutide Generics Proliferate

India Rolls Out Low-Cost Semaglutide Generics After Patent Expiry

Generics Flood India After Semaglutide Patent Lapses, Slashing Prices Up to 90%

Semaglutide Patent Expires in Brazil, Opening Door to Lower-Cost Rivals

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

Analyses Find Limited Savings as TrumpRx Reaches 54 Drugs

Brazil's Semaglutide Patent Expires Friday, Opening Door to Ozempic Generics

Brazil Nears Semaglutide Patent Expiry as Anvisa Reviews 14 Filings and Novo Nordisk Counters

Warken Moves to Raise Fixed Pharmacy Fee to €9.50 This Spring

UAE Orders Multiple Authorised Agents Per Medicine to Curb Drug Monopolies

Novo Nordisk Licenses Vivtex Platform in $2.1 Billion Push for Oral Obesity and Diabetes Drugs

German Insurer TK Sees Up to €11 Billion Annual Savings From Drug Pricing Reforms